Analysts remain positive on Teva Posted by NOWlej | Feb 2, 2025 | Israel NOWlej | 0 | The company’s 2025 guidance sent its share price tumbling, but analysts stress its investment in its innovative pipeline and debt reduction. | Read More in Front – Globes. Read More in Israel NOWlej.